Press Releases

Filters
August 24, 2004

Mexico becomes first country to approve H3 Pharma´s Sanvar® for esophageal variecal bleeding and four other indications

Read more
June 3, 2004

Debiopharm´s Eloxatin® (Oxaliplatin) awarded Prix Galien in France for innovative cancer therapy

Read more
May 13, 2004

Debiopharm exercises its Option and signs a License Agreement with the Shanghai Institute of Materia Medica for the Development and…

Read more
March 23, 2004

Debiopharm´s Pamorelin Long Acting, Formulated Using Debio® PLGA Technology, receives Final Marketing Autorisation in Germany

Read more
March 4, 2004

Yakult Honsha files Initial Submission for Marketing Authorisation of Debiopharm´s Oxaliplatin in Japan

Read more
March 2, 2004

H3 Pharma Inc. Submits new drug application to FDA for Sanvar® IR

Read more
February 24, 2004

Dyax Corp. and Debiopharm S.A. report positive Results from Phase IIa Clinical Trial with DX-890 (EPI-hNE4) in Children with Cystic…

Read more
January 19, 2004

ELOXATIN™ submitted in the United States and in Europe for the adjuvant treatment of patients with colon cancer

Read more
January 12, 2004

Eloxatin™ (oxaliplatin for injection) approved in the United States for the 1st line treatment of metastatic colorectal cancer

Read more